About Femeda
Femeda is a Healthcare company based in York (United Kingdom) founded in 2003. Developer of a disposable device for self-treatment of urinary incontinence. Femeda has raised $7.74 million across 3 funding rounds from investors including Mercia, Enterprise Ventures and Northstar Ventures. The company has 12 employees. Its chief executive, as recorded, is Andrew Tasker. Femeda offers products and services including Pelviva. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its legal entity is FEMEDA LIMITED. Its competitors include Amber Therapeutics and Jude; 2 of its 2 listed competitors have raised funding.
Company details
Founded in 2003 and based in York, United Kingdom, a disposable medical device for urinary incontinence treatment is developed. The device, shaped like a tampon, is inserted vaginally via a plastic applicator to stimulate pelvic floor muscles electrically. It operates for 30 minutes before automatic shutdown and is then discarded. Operations focus on this single-use product within the womens health sector.
- Headquarters York, United Kingdom
- Employees 12
- SectorsHealthcare
- Website femeda.com
- Social LinkedIn
- Legal Name Femeda Limited
- Date of Incorporation 08 Nov, 2002
- Jurisdiction CRAMLINGTON, ENGLAND
- Total Equity Funding$7.74M (USD)
in 3 rounds
- Latest Funding Round$5.17M (USD), Series A
Feb 2019
- InvestorsMercia
& 4 more
- Employee Count12
Products & Services of Femeda
Femeda offers a comprehensive portfolio of products and services, including Pelviva.
Device for retraining pelvic floor muscles to improve bladder control.
Funding Insights of Femeda
Femeda has successfully raised a total of $7.74M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.17 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.74M
- Total Rounds 3
- Last Round Series A — $5.17M
- First Round $2.56M
(Apr 2007)
- Investors Count 5
All 3 funding rounds of Femeda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2019 | $5.17M | Series A | – | Mercia | – |
| Oct 2015 | Series A | – | – | ||
| Apr 2007 | $2.56M | Seed | – | Northstar Ventures, Stargate Capital |
5 investors in total: 5 institutional.
Investors in Femeda
Femeda has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, Enterprise Ventures and Northstar Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early and Growth stage Venture Debt firm that does debt investments in the UK | 1982 | evgroup.uk.com | Preston, United Kingdom | |
Early-stage investments are made in UK companies across diverse sectors. | northstarventures.co.uk | Newcastle Upon Tyne, United Kingdom | ||
Investment management services are provided by Mercia to various clients. | 1982 | mercia.co.uk | ||
Manages diversified investment portfolios across various asset classes. | 2004 | stargatecapital.co.uk | Edgware, United Kingdom | |
Provides expert VC fundraising and advisory services for ambitious tech founders. | 2000 | acceleris.com | Manchester, United Kingdom |
Investor details for Femeda
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Femeda
3 people are tracked at Femeda (2 in leadership, 1 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Andrew Tasker | CEO | Leadership |
Sorcha Montgomery | Brand Director | Leadership |
Orlaith Riordan | Marketing Assistant | Team |
Complete people profiles for Femeda
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Femeda
3 dated milestones of Femeda across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Femeda is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Series A, of $5.2M.
Competitors of Femeda
Femeda has 2 listed competitors in our database, 2 of them funded. They include Amber Therapeutics and Jude.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amber-tx.com | 2021 | London, United Kingdom | $100M | Bioelectrical therapies for peripheral nervous system disorders are developed. | ||
| wearejude.com | 2021 | London, United Kingdom | $6.41M | 3 | Jude is focused on bladder health and protection products. |
Detailed competitors of Femeda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Femeda
Complete news archive for Femeda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Femeda
Femeda was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Femeda is headquartered in York, United Kingdom.
Andrew Tasker is the CEO of Femeda, as recorded in our data.
Femeda is a funded company, having raised a total of $7.74M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.56M, raised on Apr 2007.
Femeda has 12 employees.
Founded in 2003 and based in York, United Kingdom, a disposable medical device for urinary incontinence treatment is developed. The device, shaped like a tampon, is inserted vaginally via a plastic applicator to stimulate pelvic floor muscles electrically. It operates for 30 minutes before automatic shutdown and is then discarded. Operations focus on this single-use product within the womens health sector.
Femeda's top competitors include Amber Therapeutics and Jude.
Femeda offers Pelviva.
Femeda has 5 investors. Key investors include Mercia, Enterprise Ventures, Northstar Ventures, Stargate Capital, and Acceleris Capital.
Femeda operates through Femeda Limited.